VIR — VIR BIOTECHNOLOGY INC

Ownership history in ORBIMED ADVISORS LLC  ·  9 quarters on record

This page tracks every 13F SEC filing in which ORBIMED ADVISORS LLC reported a position in VIR BIOTECHNOLOGY INC (VIR). Data includes quarterly share count, position size as % of portfolio, estimated market value, and end-of-quarter stock price — sourced directly from SEC EDGAR 13F filings.

Peak position
0.49% (2024 Q3)
Avg. % of fund
0.31%
First filed
2023 Q4
Last filed
2025 Q4
Quarters held
9
Quarter Action Shares Change Chg % % of Fund Mkt Value Price (EOQ)
2025 Q4 UNCHANGED 2,380,715 — 0% 0.29% $14.4M $6.03
2025 Q3 UNCHANGED 2,380,715 — 0% 0.32% $13.6M $5.71
2025 Q2 ADDED 2,380,715 +132,466 +5.9% 0.30% $12.0M $5.04
2025 Q1 REDUCED 2,248,249 -970,368 -30.1% 0.35% $14.6M $6.48
5 older quarters hidden  —  Sign in free or upgrade to Premium to see full history
% of Fund (quarterly)    VIR price (monthly, adj. close)

Other funds also holding VIR

As of 2025 Q4 — sorted by position size

ARCH Venture Management, LLC 3Y 7Y 11.95% GSK plc 6.45% GordonMD Global Investments LP 4.02% SB INVESTMENT ADVISERS (UK) LTD 3Y 7Y 0.79% Sio Capital Management, LLC 3Y 7Y 0.45% Tejara Capital Ltd 3Y 0.33% Eagle Health Investments LP 3Y 0.32% Ikarian Capital, LLC 3Y 0.27% Clarius Group, LLC 3Y 7Y 0.21% Persistent Asset Partners Ltd 0.17%
← Back to ORBIMED ADVISORS LLC Holdings